Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus | Virology Journal | Full Text
Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial | PLOS Medicine
Immunogenicity of heterologous SARS-CoV-2 vector vaccine prime-mRNA vaccine boost vaccination strategy | Immunopaedia
Leif Erik Sander on Twitter: "1/6 Our study comparing reactogenicity & immunogenicity of homologous (2xBNT/Pfizer) vs heterologous (AZ/ChAdOx +BNT) vaccination is available https://t.co/kn1V9r7SkC Great team effort @vmcorman #FlorianKurth ...
Frontiers | Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game
Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
![PDF] Jump-starting the immune system: prime-boosting comes of age. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/24c981973d5eff6c4247827df4cc07cad983d12a/2-Figure1-1.png "PDF] Jump-starting the immune system: prime-boosting comes of age. | Semantic Scholar")
PDF] Jump-starting the immune system: prime-boosting comes of age. | Semantic Scholar
Therapeutic vaccination for treatment of chronic hepatitis B - Cargill - 2021 - Clinical & Experimental Immunology - Wiley Online Library
Frontiers | Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
IJMS | Free Full-Text | Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals
Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study - The Lancet Regional Health – Europe
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients - ScienceDirect
The mechanism of prime-boosting in relation to PD-1-expression and... | Download Scientific Diagram
Cancers | Free Full-Text | Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect
Frontiers | Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game
Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques | npj Vaccines
Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice | PLOS ONE
Prime-Boost Vaccination: Impact on the HIV-1 Vaccine Field - ScienceDirect
Frontiers | Relevance of long-lived CD8+ T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination
